Evaluating the safety and the effects on colonic compliance of neostigmine during motility testing in patients with chronic constipation

Abstract

Neostigmine significantly decreases colonic compliance in patients with refractory chronic constipation. Symptomatic bradycardia in response to neostigmine should be promptly reversed with atropine.